Haemostasis is the process of stopping bleeding at the site of an injury while maintaining normal blood flow elsewhere. It involves four main steps: vasoconstriction, primary haemostasis (platelet plug formation), secondary haemostasis (clot formation), and fibrinolysis. Secondary haemostasis, also known as the coagulation cascade, involves the intrinsic, extrinsic, and common pathways that activate coagulation factors and ultimately result in a stable fibrin clot. Vitamin K plays an important role by activating coagulation factors II, VII, IX, and X.
1 of 24
Download to read offline
More Related Content
Coagulation Cascade with primary and secondary.pptx
2. Haemostasis is a process that prevents bleeding at
the site of an injury while maintaining normal
blood flow elsewhere
4 Major Steps
Vasoconstriction
Primary Haemostasis (platelet plug formation)
Secondary Haemostasis (clot formation)
Fibrinolysis 2
3. Vessel's first response to injury
Greater the trauma more will be the spasm ,sometimes it can occlude the vessels
completely
Triggers
Direct injury to vascular smooth muscle
Secretion of nitric oxide, prostaglandins stop; secretion of endothelin begins further contraction
Nervous system reflexes initiated by local pain receptors.
Effects
Slows down the flow of blood via the vessel
Increases the period of contact between platelets and exposed collagen
3
4. Process by which a platelet plug is formed
Steps
1,Exposure
Endothelial injury Damage to endothelial cells
exposes collagen
Damaged cells release Von Willebrand factor which
binds to the exposed collagen
4
5. 2,Adhesion
GP1B surface proteins on platelets bind
to Von Willebrand factor
Von Willebrand factor is a large
glycoprotein that is present in the
plasma and endothelium
Once VWF binds to the subendothelium,
it exposes multiple binding sites for
platelets to adhere, activate, and
aggregate.
5
6. 6
3, Activation
Platelet changes shape ,first swells then contracts & forms arms to grab other
platelets, releases more von Willebrand factor, serotonin, calcium, ADP,
thromboxane A2 (positive feedback loop)
ADP, thromboxane A2 result in GPIIB/IIIA expression
8. Clinically
Patient can be asymptomatic
Skin bleeding Petechiae , Purpura ,Ecchymoses
Mucosal Bleeding Epistaxis ,Gingival Bleeding, Menorrhagia, Haemoptysis
Investigations
Platelet Count
Bleeding Time
Platelet Aggregometry(Best Method)
8
9. Aka Secondary Haemostasis.
End product - fibrin meshwork.
Its called a cascade as from one stage to the
next in the Cascade, a greater amount of
proenzyme is involved resulting in
amplification.
Each factor is named in the order of their
discovery.
Consists of three pathways, the extrinsic,
intrinsic, and common pathways, that interact
together to form a stable blood clot 9
18. 18
X
X
a
Intrinsic pathway begins when factor XII or the
Hageman factor is exposed to collagen,
kallikrein, and high molecular weight kininogen
(HMWK) and is subsequently activated.
Factor XIIa activates factor XI into XIa.
With a calcium ion, factor XIa activates factor
IX
Then, factor IXa, factor VIIIa, and calcium form
a complex to activate factor X.
Factor VIII is found in the blood and is often
activated by thrombin (factor IIa).
aPTT measures both Intrinsic and Common
21. 21
X Xa
The extrinsic pathway begins when there is
injury to the surrounding tissues
Which exposes tissue factor (factor III) to the
blood.
Tissue factor then becomes bound with
calcium and factor VIIa to activate factor X
Factor VII is present in the blood and
requires vitamin K to be activated.
PT measures both Extrinsic and common
pathway
23. 23
Vitamin K regulates blood coagulation
converts coagulation factors into mature
forms
Quinone reductase reduces vitamin K quinone
(dietary form) into vitamin K hydroquinone
Vitamin K hydroquinone donates electrons to
y-glutamyl carboxylase,
Which Activates the enzyme
Adds carboxyl group to glutamic acid residues
on proteins
This coverts the clotting factors to its active
form
Vit K dependant Factors are
II, VII, IX, X
#4: Endothelin isa 21-amino acid long peptide that is a vasoconstrictor produced from endothelial cells, vascular smooth muscle cells (VSMC), macrophages, and the renal medulla.